Tirzepatide

Service Description

Tirzepatide is a novel medication used primarily for the treatment of type 2 diabetes. It is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, meaning it activates receptors for both GIP and GLP-1, hormones involved in blood sugar regulation and appetite control. This dual activation enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite, leading to better blood glucose control and weight loss.